Mycosis fungoides and total skin electron beam radiation.
Jones
G W
GW
Wilson
L D
LD
D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D018572:Disease-Free Survival; D004583:Electrons / Q000627:therapeutic use; D006801:Humans; D008466:Mechlorethamine / Q000627:therapeutic use; D009182:Mycosis Fungoides / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy*; D011701:PUVA Therapy; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D012751:Sezary Syndrome / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy; D012878:Skin Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy*; D016019:Survival Analysis; D016896:Treatment Outcome
D018906:Antineoplastic Agents, Alkylating; D008466:Mechlorethamine